Two Rapid Resolution Liquid Chromatography (RRLC) methods have been developed and validated for simultaneous quantification of eight major ginsenosides from Panax species, namely, R 1 , R g1 , R e, R f, R b1 , R b2 , R c , and R d , and flavonoids from Epimedium species, namely, epimedins A, B, and C and icariin. The analyses were performed using an Agilent 1200 series RRLC system with Phenomenex Luna C18-HST and Zorbax Eclipse XDB columns. The separation was performed with a gradient mobile phase of A (pure water) and B (acetonitrile) at a flow rate of 1.0 mL/ min and 2.5 mL/min, respectively. Both columns were kept at 40 o C with the detection wavelength set at 203 nm. Specific eluted compounds were identified by using reference samples of ginsenosides R 1 , R g1 , R e , R f , R b1 , R c , R b2 , and R d , and epimedins A, B, C and icariin. Baseline separation was achieved in less than 15 minutes for the Phenomenex Luna column and 4 minutes for the Zorbax Eclipse column. Characteristic RRLC profiles were established for complex mixtures of ginsenosides from Panax species and flavonoids from Epimedium species. Both methods developed here are effective for the quality control of formulated products containing both Panax and Epimedium varieties.
Up to date, over 60 species of Epimedium have been reported, but only five of these are recorded in the Chinese Pharmacopeia, namely, Epimedium bravicornum Maxim., E. sagittatum (Sieb. et Zucc) Maxim., E. koreanum Nakai, E. pubescens Maxim. and E. wushanense T.S. Ying [1c] . Epimedium species have been used extensively in Traditional Chinese Medicine for their warming or "Yang" tonic effect, which shows great therapeutic properties for the kidney [2a,2b] , enhances the immune system [2c] , and increases sperm production, therefore being useful for sexual enhancement [2d,2e] .
The active constituents of ginseng roots, known as ginsenosides (triterpenoid saponin glycosides), contribute primarily to the pharmacological effects [3a-3c] . There are two types of ginsenosides, both with a similar dammarane chemical skeleton, 20S-protopanaxadiol compounds, such as R b1 , R b2 , R c and R d , and 20S-protopanaxatriol compounds, which include R g1 , R e, R f and R 1 [ Figure 1 ] [3d] . More than 30 ginsenosides have been identified in Panax species [3e], but R b1 , R b2 , R c , R d , R e and R g1 are the six major ginsenosides that represents more than 90% of the total ginsenoside content in ginseng roots, with R f used for identification of P. ginseng and R 1 to identify P. notoginseng [3f-3h] .
Flavonoids are the main active chemical constituents of Epimedium species, the four major flavonoids contributing to their effects being epimedins A, B, and C, and icariin [4a,4b] . These biologically active constituents are flavonol glycosides with an isoprenyl group substituted on carbon 8 [ Ma et al. (1)
(3) (4) (5) A new type of P. quinquefolius from Maryland, USA, has been highlighted to have a high R g1 /low R e ratio [3b,8d] . This is in contrast to that stated in the USP and reported for the more extensively investigated type of P. quinquefolius, which has a low R g1 /high R e ratio [3g]. The R g1 /R e ratio between the two types of this species will vary according to the place of cultivation. However, the ratio for protopanaxadiol ginsenosides is relatively stable. In this communication, a new rapid analytical method has been developed, which mainly focuses on the qualitative and quantitative analysis of the protopanaxadiol group that is sufficient for the identification of the commonly used Panax species.
As mentioned earlier, herbs are often used in combination and, therefore, methods developed for single herb analysis may not be suitable for formulated products. Rapid Resolution Liquid Chromatography (RRLC) enables simultaneous analysis of multiple compounds. This technique has been proven for high sensitivity, better resolution and a rapid analysis compared with the conventional HPLC system [7b,8e]. One of the methods reported here was developed after consideration of both the active ingredients and the HPLC profiles of extracts of Panax and Epimedium species. It allows separation of ginsenosides R g1 and R e and requires fifteen minutes to complete the analysis. Another method that relies on the protopanaxadiol group identification within formulated products can be completed in even a shorter time of only four minutes. Both methods are sufficient for the identification of the formulated products containing Panax and Epimedium species.
Whilst developing the RRLC method, scrutiny of the literature reports indicated a preference for a UV detector and a mobile phase commonly employing formic acid (HCO 2 H) to achieve better chromatographic separation [7b] . In this study, H 2 O -acetonitrile (CH 3 CN) was chosen as the mobile phase since their combination allows for good chromatographic separation while having the advantage of being non-acidic. In the mobile phase for the ginsenosides, characteristic UV absorption was obtained at 203 nm, while flavonoids in Epimedium had a maximum absorption at 270 nm and another at 205 nm. The flavonoids from Epimedium have a relatively stronger absorption due to their aromatic nature, and, therefore, the detection wavelength at 203 nm was selected to analyze the twelve bioactive compounds in Panax and Epimedium species in a single run.
The linearity for each of the eight ginsenosides, epimedins A, B, and C, and icariin were established by plotting the peak area (Y) versus concentration (X), expressed by the equations given in Table 1 . Correlation study verified the linearity of the calibration curves and the correlation coefficients were all above 0.999. Peaks were assigned by comparing the retention time of samples with reference standards and were demonstrated over a range of 10 -2208 μg/mL. The limit of detection (LOD) and limit of quantification (LOQ) for the eight ginsenosides, epimedins and icariin were estimated at signal-to-noise ratios (S/N) of 3 and 10, respectively. The LOD and LOQ for the bioactive compounds in Panax and Epimedium species were ≤ 6.7 µg/mL and less than 12.2 µg/mL using the Phenomenex Luna column and ≤ 3.1 µg/mL and less than 8.6 µg/mL for the Zorbax Eclipse column, respectively. All LOD and LOQ were obtained with 1 µL sample injections. Figure 3 shows the profile of the major chemical constituents from Panax and Epimedium species using the Phenomenex Luna column. Twelve marker compounds, namely ginsenosides R 1 , R g1 , R e , epimedins A, B, and C, icariin, R f , R b1 , R c , R b2 and R d with R g1 and R e were successfully separated. Figure 3A shows the profile of the reference standards. Figures 3B-D show the separation of active compounds of three different Panax species and Epimedium species.
The mixed reference standard solution was analyzed in triplicate to determine the reproducibility of the method developed. compounds were between 98.3 -100.7%, with RSD less than 1.9% using the Phenomenex Luna column and 96.1 -102.9%, with RSD less than 2.8% using the Zorbax Eclipse column.
The Phenomenex Luna and Zorbax Eclipse columns were compared with each other in triplicate to ensure that similar results were obtained. The percentage of concentration tested on the Zorbax Eclipse column to the Phenomenex Luna column was 98.1 -102.5%. Therefore, these results show precision, accuracy, recovery and good repeatability.
The existence of the two types of P. quinquefolius roots with high R g1 /low R e and low R g1 /high R e , suggests that R g1 and R e from the protopanaxatriol group cannot be relied upon for identification of Panax species. However, the Zorbax Eclipse column can be employed to distinguish and identify the three commonly used Panax species by comparison of the HPLC profiles of the protopanaxadiol group ginsenosides, namely R b1 , R c , R b2 and R d (Figure 4) . Figure 4 shows the profile of the major chemical constituents of Panax and Epimedium species using the Zorbax Eclipse column. Ten marker compounds, namely, ginsenosides R 1 , epimedins A, B, and C, icariin, R f , R b1 , R c , R b2 and R d are presented. Figure 4A shows the profile of the reference standards. Figures 4B-D show the separation of active compounds of three different Panax species and Epimedium species.
Unfortunately, compounds R g1 and R e cannot be separated using the Zorbax Eclipse column, but the total concentration of the protopanaxatriol and protopanaxadiol group can aid in the determination of the type of P. quinquefolius. For the Maryland P. quinquefolius (high R g1 /low R e ratio), in the 28 samples tested, the total ginsenoside content of the protopanaxadiol group was around 45%, which is lower than the protopanaxatriol R g1 + R e ratio (normally about 55%) [3b] . For the traditional P. quinquefolius (low R g1 /high R e ratio), in the ten samples tested, the protopanaxadiol group was around 54%, which is higher than the protopanaxatriol group, at around 46%.
Next, the RRLC method was applied to four commercial samples of Panax and Epimedium formula products by using the Phenomenex Luna and Zorbax Eclipse columns (Table 3) to compare the contents of the twelve marker compounds. Figures 3 and 4 show the standard RRLC chromatograms of these compounds.
There is evidence that P. ginseng and P. quinquefolius have opposing effects [1a] , but many commercial ginseng products containing both Panax species do exist on the market. Figure 5 shows the chromatogram of the ginseng product claiming to be pure North American ginseng extract. However, according to the rapid analysis using the Zorbax Eclipse XDB column, the product does contain North American ginseng roots, but is contaminated with Asian ginseng roots. The R b2 /R b1 ratio for P. quinquefolius should be less than 0.1, but analysis shows that the ratio is around 0.3, and, in addition, there is the clear presence of R f in the HPLC chromatogram ( Figure 5 ).
The analysis shows that some products (CPC-GE-001, CPC-GE-002, CPC-GE-003) available on the market do not meet claimed concentrations. Many organizations, such as Health Canada, the FDA and other Natural Health Product Regulatory Affairs departments are demanding identification of the herbs and botanical products. Therefore, for the Natural Health Product industry to meet these requirements, rapid analysis methods are crucial for the identification of Panax and Epimedium species, as well as to evaluate the quality of the commercial ginseng and Epimedium products. The two methods developed and described in this communication are essential for such identification and evaluation of Panax species. The Phenomenex Luna column was able to fully separate eight major ginsenosides in Panax and four flavonoids in Epimedium species for both quantitative and qualitative analysis in less than 15 minutes.
The existence of a different type of P. quinquefolius with a high R g1 / low R e ginsenoside ratio has excluded quality control reliance on this parameter for identification of Panax species.
Nevertheless, the content ratio of protopanaxadiol to protopanaxatriol can be used to distinguish preparations containing mature ginseng roots, fiber and also identifying the two types of P. quinquefolius roots. In the latter case, the HPLC profile of the protopanaxadiol group enables effective determination of the Panax species purity. Many commercial ginseng products claim to be North American ginseng, but Asian ginseng is added to the formulated product as well. The R b2 /R b1 ratio for North American ginseng, which is expected to be less than 0.1, allows us to conclude that the protopanaxadiol group is enough for the identification of the Panax species; therefore, the method using the Zorbax Eclipse XDB column was established to complete the analysis rapidly in only four minutes.
Experimental

Materials and reagents:
Acetonitrile and methanol of HPLC grade were from Fisher Scientific Canada. Deionized water was purified by Barnstead's Nanapure ultrapure water system (Barnstead, USA). Ginsenoside standards R g1 , R e , R b1 , R c , R b2 , R d , R f and icariin standard were purchased from Sigma (USA), ginsenoside R 1 was purchased from the National Institute of drug control and biological products (China) and epimedins A, B, C were from Biopurify (Chengdu, China). Epimedium plants were collected from local growers. P. quinquefolius, fresh and dried root samples, were mostly from plants grown in North America. P. ginseng roots were collected from ginseng growers in Korea and China. P. notoginseng samples were from Kunming Institute of Botany in China. Membrane filters were purchased from VWR International (Mississauga, Canada). R 2 , Correlation coefficient of regression equations; LOD, limit of detection (S/N = 3); LOQ, limit of quantification (S/N = 10). 1.78 R 2 , Correlation coefficient of regression equations; LOD, limit of detection (S/N = 3); LOQ, limit of quantification (S/N = 10). *, Ginsenoside R g1 /R e Reference standard was prepared in the ratio of 1/3. 
Sample and Reference standard solution preparation:
Panax species powder extract (50 mg), claiming to contain 10% ginsenosides, and Epimedium powder extract claiming 10% icariin were accurately weighed and dissolved in 100% methanol in a 10 mL volumetric flask and made to volume, then ultra-sonicated at 37 o C for 20 min. Panax species root powder (100 mg) was accurately weighed and dissolved in 75% aqueous methanol in a 10 mL volumetric flask, made to volume, then ultra-sonicated at 37 o C for 20 min. The extract solutions were cooled to room temperature, the supernatant collected, and filtered through a membrane filter (0.2 µm) for further analysis. Each of the prepared solutions (1 µL) was injected into the RRLC system. Each sample was injected in triplicate and the RSD calculated for all the samples. Each of the individual standards (R 1 , R g1 , R e , R f , R b1 , R c , R b2 , and R d , epimedins A, B, and C, and icariin) were accurately weighed and dissolved in pure methanol to yield concentrations of 179. 00, 29.55, 89.10, 37.37, 223.58, 37.42, 30.45, 45.00, 23.98, 39.58, 60.18 and 90 .00 µg/mL, respectively. All the solutions were stored at 4 o C in a refrigerator. Each of these (1 µL) was injected into the RRLC system. All analyses were performed on an Agilent 1200 Series Rapid Resolution Liquid Chromatography (RRLC) system (Agilent, CA, USA) equipped with a binary pump SL, vacuum degasser from a high-speed, high-performance auto plate-sampler SL for high area precision, and a thermostated column compartment SL that reaches up to 100 o C. This system was controlled by an Agilent ChemStation revision B.01.01. A Phenomenex Luna 2.5 µm C18 (2)-HST (3.0 mm x 100 mm) column, and a Zorbax Eclipse XDB-C18 1.8 µm (4.6 mm x 50 mm) column were employed at 40 o C. Gradient elution with mobile phase A (pure water) and B (acetonitrile) was used at a flow rate of 1.00 mL/min for the Phenomenex Luna column and 2.50 mL/min for the Zorbax Eclipse XDB column. For the Phenomenex Luna column, gradient elution was employed as follows: 19.7% -19.7% B at 0 -9 min; 19.7% -30% B at 9 -10 min; 30 -30% B at 10 -11 min; 30 -50% B at 11 -16 min; 50 -100% B at 16 -18 min, followed by a re-equilibration for another 2 min. For the Zorbax Eclipse XDB column gradient elution was employed as follows: 22 -22% B at 0 -1.6 min; 22 -40% B at 1.6 -3.5 min; 40 -50% B at 3.5 -5 min; 50 -100% B at 5 -6 min, followed by a re-equilibration period of 2 min.
